Abbott Laboratories is linking its continuous glucose monitoring with automated insulin delivery by entering a global partnership with health tech giant Medtronic. The pairing of Abbott's leading ...
At the scientific sessions of the American Diabetes Association, multiple studies were presented showing benefits in Type 2 diabetes through a combination of continuous glucose monitoring and ...
Multiple developers of connected diabetes hardware have announced plans this week to link their insulin pumps with continuous glucose monitors from Abbott—including its current FreeStyle Libre system ...
Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.
Hosted on MSN
Barbie’s first doll with Type 1 diabetes comes complete with continuous glucose monitor, insulin pump
There’s a brave, new Barbie in the box. Mattel announced the release of the first-ever Barbie doll with type 1 diabetes, complete with a continuous glucose monitor and an insulin pump in Barbie’s ...
With the prevalence of diabetes quadrupling in recent decades and currently impacting more than 500 million people in the world, it is no surprise that the technology for insulin delivery has also ...
Mattel partnered with leading diabetes organization Breakthrough T1D to ensure that the medical devices were accurate The doll, which retails for $10.99, comes with a continuous glucose monitor and ...
Mattel’s new Barbie doll is a Type 1 diabetic with an insulin pump and glucose monitor on her arm. The new brunette Barbie is the latest in a line of dolls the American toy giant has rolled out, ...
Mattel announced the release of the first-ever Barbie doll with type 1 diabetes, complete with a continuous glucose monitor and an insulin pump in Barbie's signature pink. Physicians are in short ...
Leading diabetes organization Breakthrough T1D partnered with Mattel on the doll to ensure the devices were medically accurate Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results